Pillar 01
In-house developed medtech
Bringing innovative in-house developed medtech products to market with superior and well-documented clinical performance, health economics and sustainability by design.
About Observe Medical
We develop solutions with a documented ability to improve patient outcomes and enable more effective use of healthcare resources. Our next step is digitising it.
A Nordic company with global reach, committed to taking responsibility for reducing infections and optimising workflows in critical care.
The company
A Nordic company with global reach
Observe Medical ASA (OBSRV, Euronext Expand Oslo) is headquartered in Oslo, with R&D, Quality and Regulatory, Commercial, and logistics managed out of our Nordic base. Our solutions are used by ICU teams across 46 countries, from university hospitals in Northern Europe to critical care units in Southeast Asia and the Middle East.
The company is built on a 30-year heritage of building clinical standards in urine output monitoring. We have now extended that standard with published clinically relevant data and superior health-economic benefits. The next step will be to transition the market from a mechanical to a digital solution.
46
Countries served
30
Years of clinical heritage
3
Offices – Oslo, Copenhagen & Gothenburg
Our ambition
A Nordic medtech platform.
Built to carry more than our own products.
Two strategic pillars drive the company.
Pillar 02
The Nordic ecosystem
Representing the Nordic ecosystem of innovative companies within the medtech world by offering scalable solutions in manufacturing, regulatory, quality and, not least, commercialisation of their solutions.
Leadership
The team behind the products
A clinical and commercial leadership team with deep experience in critical care, medical device regulation, and Nordic medtech scale-up.
Jørgen Mann
Chief Executive Officer
Jørgen brings more than 20 years of senior management experience from global medtech companies. He focuses on innovation and entrepreneurship across every part of the business, accelerating growth through a solid strategic approach and visible leadership built on strong values and clear communication.
Johan M. Fagerli
Chief Financial Officer
Johan brings 20 years of experience in financial management, business controlling and accounting. He has held these roles across multiple industries, including real estate, road construction and telecom.
Torben Sandgren
Business Development Director
Torben brings a robust background in business development and commercial growth within the medtech sector, identifying new opportunities, strengthening partnerships and driving market expansion. He has previously served as CEO in the neurotech industry and held senior urology and incontinence roles at Coloplast, Unomedical and Convatec.
Arun Kesavan
Sales Director, Middle East & Southeast Asia
Arun brings more than 26 years of international experience in medical device commercialisation, market entry strategy and regional business leadership across India, Southeast Asia and the Middle East. He has led the launch of multiple innovative healthcare products and built strategic alliances with healthcare institutions, distributors and clinical leaders in emerging markets.
Dorthe Jensen
Sales Director, Europe & South America
Dorthe brings extensive experience from international medical device sales, spanning both consumables and capital equipment. She has built and managed distribution partners across the globe, giving each partner the support needed to turn strong relationships into commercial growth.
Board of Directors
Governance and strategic oversight
Our board combines international medtech leadership with deep commercial and operational experience across global healthcare markets.
Terje Bakken
Chairman of the Board
Terje Bakken is an experienced investor and board chair, with more than 28 years of experience in private equity, active ownership and company building. He has extensive experience working with growth companies, management teams and boards, with particular focus on strategy, international expansion, financing, M&A and value creation.
He brings a hands-on, commercially focused approach to scaling businesses and supporting management through periods of significant growth and transformation.
Line Tønnessen
Board Member
Line Tønnessen is a partner in Reiten & Co, bringing a strong analytical and strategic background to the Board. Ms. Tønnessen has extensive experience across equity and debt capital markets, bank financing, mergers and acquisitions, and sustainability initiatives, as well as board-level experience from various other industries and listed companies.
She holds a Bachelor of Business Administration from BI Norwegian Business School and an MBA in Finance from the Norwegian School of Economics (NHH). She is a Certified European Financial Analyst (CEFA).
Anoar Solberg
Board Member
Anoar Solberg is an accomplished leader with over 16 years of experience in the medical device industry across 23 markets, specifically within Abbott Diabetes Care. He possesses a robust, cross-functional background, having led key departments including sales, marketing, market access, business excellence, business development, and finance.
He holds an M.Sc. in Marketing from BI Norwegian Business School, Oslo.
May-Britt Moeslund-Hansen
Board Member
May-Britt Moeslund-Hansen is CEO and Co-founder of Dialysis International ApS and brings more than 30 years of experience across healthcare and medtech. She has broad expertise in strategy and general management and a strong track record establishing and scaling businesses globally.
She has held senior leadership roles at companies including Unomedical, NxStage Medical Inc., and Fresenius Medical Care, driving operational excellence and business development across Europe, the Middle East, Asia, Latin America, and other international markets.